132nd MAINE LEGISLATURE
LD 697 LR 293(02)
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing
Fiscal Note for Bill as Amended by Committee Amendment " "
Committee: Health Coverage, Insurance and Financial Services
Fiscal Note Required: Yes
             
Fiscal Note
FY 2025-26 FY 2026-27 Projections  FY 2027-28 Projections  FY 2028-29
Net Cost (Savings)
General Fund $223,422 $298,362 $311,162 $321,582
Appropriations/Allocations
General Fund $223,422 $298,362 $311,162 $321,582
Fiscal Detail and Notes
This bill includes ongoing General Fund appropriations of $223,422 in fiscal year 2025-26 and $298,362 in fiscal year 2026-27 to the Office of Affordable Heath Care for one Public Service Manager III position, one Comprehensive Health Planner II position, and related All Other costs to support the Prescription Drug Affordability Board with strategic direction, administrative work, and subscriptions and contracts to be used to obtain commercial drug pricing data and for consulting services to support data analysis effective October 1, 2025.